Status:
COMPLETED
Improved Breast MRI With SWIFT
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Today's medical imaging methods have insufficient specificity for reliable differentiation between benign and malignant breast lesions in patients. Pathologic evaluation is currently the only way to o...
Detailed Description
Patients will be asked to come to the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota. Researchers will interview the patient and describe procedures and risks. An intrave...
Eligibility Criteria
Inclusion
- Women with a clinically or mammographically identified suspicious breast mass that is likely to be biopsied or surgically removed.
Exclusion
- Pregnancy
- Ferromagnetic implants
- History of shotgun wounds and shrapnel
- Obesity (\>250 pounds)
- Cardiac pacemaker
- Incompatible implanted medical device
- Severe claustrophobia
- Major surgeries with potential of ferromagnetic implants
- Severe asthma and allergies
- i-STAT system, a handheld blood analyzer (I-STAT) creatinine test, estimated glomerular filtration rate (GFR) \<30
- Metallic object (greater than 2 cm in length) in the breast
- Metallic ink tatoo within 20 cm of the breast (approximately 8 inches)
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01156987
Start Date
August 1 2009
End Date
August 1 2015
Last Update
March 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Magnetic Resonance Research
Minneapolis, Minnesota, United States, 55455